115432, Moscow, 6 Proektiruemyi proezd № 4062, bld. 2

Tel.:+7 499 922 06 62 add. 1060

E-mail: info@aptos.ru

Our history counts over two decades of innovation and product development. The methods were invented by the Georgian plastic surgeon Dr. Marlen Sulamanidze and further developed

by his sons plastic surgeons Dr. George Sulamanidze and Dr. Konstantin Sulamanidze. Being in the forefront of the technological development helped us meet patient's ever expanding expectations: minimal recovery time, immediate and natural results. We are proud to be constantly improving our industry-leading portfolio of innovative products.


Throughout our history quality has been our trademark. APTOS heritage counts up to 30 threads and more than 50 methods shared worldwide via selected professional distribution partners. APTOS threads and methods have obtained 18 patents of which 8 are international.

To date we have gathered a community of more than 10k certified doctors around APTOS. Being the creators of the pioneering product, we have constantly met the aim to be a reliable partner for the practitioners worldwide.


Sharing the experience and knowledge has always been a primary goal for APTOS creators. We are more than our products - an ecosystem of training centers, materials and value-added offers was designed to support the doctors to deliver to their patients the very best services.

The expertise we've been sharing with the doctors worldwide has been crucial in helping each and every patient feel better and as a result look better.

APTOS is defining the future of aesthetic medicine. Our Mission is to improve the technology to

the point when it fully eliminates the possibility of human error.

All information contained in this section of the website is intended solely for healthcare professionals – medical and pharmaceutical professionals.

If you are not a healthcare professional, in accordance with the provisions of the current legislation of the Russian Federation, you do not have the right to access the information posted in this section of the website, and therefore we ask you to immediately leave this section of the website.